Joint Appointment with Department of Pharmacology and Medicine
Research Interests
Personalized Medicine
Cancer
Nanomedicine
Selected Publications
Ho D, Wang CH, Chow EK; Nanodiamonds: The intersection of nanotechnology, drug development, and personalized medicine.; Sci Adv. 2015 Aug 21;1(7):e1500439
Mohd Abdul Rashid MB, Toh TB, Silva A, Nurrul Abdullah L, Ho CM, Ho D, Chow EK; Identification and Optimization of Combinatorial Glucose Metabolism Inhibitors in Hepatocellular Carcinomas.; J Lab Autom. 2015 Mar 30.
Wang X, Low XC, Hou W, Abdullah LN, Toh TB, Mohd Abdul Rashid M, Ho D, Chow EK.; Epirubicin-adsorbed nanodiamonds kill chemoresistant hepatic cancer stem cells.; ACS Nano. 2014 Dec 23;8(12):12151-66.
Toh TB, Lee DK, Hou W, Abdullah LN, Nguyen J, Ho D, Chow EK; Nanodiamond-Mitoxantrone Complexes Enhance Drug Retention in Chemoresistant Breast Cancer Cells.; Mol Pharm. 2014 Jun 4.
Chow EK (co-corresponding), Ho D; Cancer nanomedicine: from drug delivery to imaging; Sci Transl Med. 2013 Dec 18;5(216):216rv4. doi: 10.1126/scitranslmed.3005872.
Man HB, Kim H, Kim HJ, Robinson E, Liu WK, Chow EK (co-corresponding), Ho D; Synthesis of Nanodiamond-Daunorubicin Conjugates to Overcome Multidrug Chemoresistance in Leukemia; Nanomedicine-Nanotechnology Biology and Medicine; 2013 Aug 2. doi:pii: S1549-9634(13)00355-9. 10.1016/j.nano.2013.07.014.
Chow EK, Fan L, Chen X, Bishop JM; Oncogene-specific formation of chemoresistant murine hepatic stem cells; Hepatology. 2012 Oct;56(4):1331-41. doi: 10.1002/hep.25776. Epub 2012 Aug 27.
Chow EK, Zhang XQ, Chen M, Lam R, Robinson E, Huang H, Schaffer D, Osawa E, Goga A, Ho D; Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment; Sci Transl Med 2011 Mar 9;3(73):73ra21
